{
    "Trade/Device Name(s)": [
        "ADVIA Centaur FT4",
        "ADVIA Centaur T4"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K132249",
    "Predicate Device Reference 510(k) Number(s)": [
        "K080167",
        "K905532",
        "K971418"
    ],
    "Regulatory Class": "Class II, Class I",
    "Product Code(s)": [
        "CEC",
        "KLI"
    ],
    "Summary Letter Date": "September 13, 2013",
    "Summary Letter Received Date": "August 12, 2013",
    "Submission Date": "August 9, 2013",
    "Regulation Number(s)": [
        "21CFR862.1695",
        "21CFR862.1700"
    ],
    "Regulation Name(s)": [
        "Free thyroxine test system",
        "Total thyroxine test system"
    ],
    "Analyte Class(es)": [
        "endocrine",
        "chemistry"
    ],
    "Analyte(s)": [
        "Free thyroxine (FT4)",
        "Thyroxine (T4)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Heparin tube",
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ADVIA Centaur",
        "ADVIA Centaur XP"
    ],
    "Method(s)/Technology(ies)": [
        "Radioimmunoassay (FT4)",
        "Enzyme immunoassay (T4)"
    ],
    "Methodologies": [
        "Quantitative determination"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for ADVIA Centaur FT4 and T4 assays including addition of pediatric reference intervals for thyroid function testing.",
    "Indications for Use Summary": "For in vitro diagnostic use in the quantitative determination of free thyroxine (FT4) and thyroxine (T4) in serum or plasma (heparinized or EDTA), using ADVIA Centaur and ADVIA Centaur XP systems, aiding in the diagnosis and treatment of thyroid disease.",
    "fda_folder": "Clinical Chemistry"
}